Study to assess risk of atrial fibrillation
Part of Heart & circulation clinical trials.
This study looks at how to better judge a person’s risk of developing atrial fibrillation, a type of irregular heartbeat. You may help researchers by completing interviews and assessments that guide future risk estimates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 85 years old
- Agree to take part by signing informed consent
- Understand German well enough to read study documents
- Be able to answer computer-based questions without needing translation
- Be physically and mentally able to cooperate with study tests and interviews
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a “clinical cohort” study, meaning it follows adults with certain heart rhythm issues to understand them better. Your participation may help researchers learn what to expect and how best to support people over time.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
This study focuses on people who have atrial fibrillation (an irregular heartbeat) and whose diagnosis was made within the last year. It aims to understand how atrial fibrillation progresses, which could help guide better monitoring and future care.
This study records and follows people under 35 who have their first episode of an irregular heartbeat. It aims to better understand this condition early on and how it shows up in real life.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.